A novel HBV drug for effective cure of chronic hepatitis b
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2110065
- Recipient
-
Hbvtech, L.l.c UEI WEXNYHY4EZB5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $279,854
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Germantown, MD, USA
Award details come from USAspending.gov.
About this award
Hbvtech received a $279,854 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support Hbvtech's research from May 2021 through April 2023 to develop a novel hepatitis B virus drug aimed at effectively curing chronic hepatitis B. The Military Medical Research and Development program seeks to transform military and public health through innovative medical research solutions, including investigating treatments for battlefield injuries and illnesses. Hbvtech's research aligns with this program in exploring new options for this infectious disease.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $279,854 |
Quick answers
Who received award W81XWH2110065?
W81XWH2110065 was awarded to Hbvtech, L.l.c by Medical Command (Department of the Army) on May 1, 2021.
How much is award W81XWH2110065 worth?
$279,854 has been obligated on W81XWH2110065.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award